FDA approves second brain imaging drug to help evaluate patients for Alzheimer disease, dementia
Oct 28, 2013
The US Food and Drug Administration has approved Vizamyl (flutemetamol F 18 injection), a radioactive diagnostic drug for use with positron emission tomography (PET) imaging of the brain in adults being evaluated for Alzheimer disease and dementia.
Breakthrough offers first direct measurement of spinal cord myelin in multiple sclerosis
Sep 23, 2013
Case Western Reserve University School of Medicine scientists have developed a novel molecular probe detectable by PET imaging. The new molecular marker, MeDAS, offers the first noninvasive visualization of myelin integrity of the entire spinal cord at the same time, as published today in an article in the Annals of Neurology.
Largest study of epilepsy patients ever conducted reveals new and surprising genetic risk factors
Aug 12, 2013
Neurologists and epilepsy researchers have identified 329 random genetic mutations associated with 2 of the most severe forms of epilepsy, according to a paper published today in Nature. This study sheds light on why some with an elevated risk for epilepsy never get the disease and why certain medications work better for some patients than others.
Newly identified bone marrow stem cells reveal markers for amyotrophic lateral sclerosis
Jul 10, 2013
Using samples of stem cells derived from the bone marrow of non-genetic amyotrophic lateral sclerosis patients, a team of researchers have uncovered 4 different biomarkers that characterize the non-genetic form of the disease.
Researcher develops protein to protect and restore nerve cell communications
Jun 14, 2013
A Tel Aviv University researcher has developed a new peptide, called NAP or Davunetide, that has the capacity to both protect and restore microtubule function. These findings, which were reported in the journal Neurobiology of Disease, indicate that NAP could be an effective tool in fighting some of the most debilitating effects of neurodegenerative diseases.
Researchers find far-reaching, microvascular damage in uninjured side of brain after stroke
May 20, 2013
Although the effects of acute stroke have been widely studied, brain damage during the subacute phase of stroke has been a neglected area of research. Now, a new study by the University of South Florida reports that within a week of a stroke caused by a blood clot in 1 side of the brain, the opposite side of the brain shows signs of microvascular injury.